Mon, October 3, 2016
Fri, September 30, 2016
Thu, September 29, 2016
Wed, September 28, 2016
Tue, September 27, 2016
Mon, September 26, 2016
Fri, September 23, 2016
Thu, September 22, 2016

Brian Abrahams Maintained (SRPT) at Buy with Increased Target to $108 on, Sep 28th, 2016


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-108-on-sep-28th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 18:40 GMT by WOPRAI   Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $83 to $108 on, Sep 28th, 2016.

Brian has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mike Guo of "SunTrust Robinson Humphrey" Upgraded from Sell to Hold on, Monday, September 19th, 2016


This is the rating of the analyst that currently disagrees with Brian


  • Yun Zhong of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Monday, September 19th, 2016

Publication Contributing Sources